What is brucellosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Brucellosis should be treated with a six-week regimen of doxycycline combined with either streptomycin for 2–3 weeks or rifampicin for six weeks, as this is the optimal treatment for uncomplicated cases, according to the Ioannina recommendations 1. The treatment of brucellosis is complex and requires the administration of more than one antibiotic for a prolonged period.

  • The optimal treatment regimen is based on a combination of doxycycline and either streptomycin or rifampicin, with gentamicin being considered an acceptable alternative to streptomycin 1.
  • The use of doxycycline and streptomycin or rifampicin for six weeks is recommended as the first-line treatment, while all other regimens or combinations should be considered second-line 1.
  • The development of a common global therapeutic language for human brucellosis and future clinical trials would help to solve controversies regarding the disease and provide more effective treatment options 1. The treatment of brucellosis requires careful consideration of the potential complications and the need for prolonged antibiotic treatment to completely eradicate the infection.
  • The standard regimen of doxycycline and streptomycin or rifampicin is effective in treating uncomplicated cases, but more severe cases may require extended treatment duration or alternative regimens 1.

From the Research

Treatment of Brucellosis

  • The treatment of human brucellosis is controversial, with various antibiotics and combinations being used 2.
  • A study comparing doxycycline-rifampin versus doxycycline-rifampin-gentamicin found that the addition of gentamicin decreased the rate of relapses 3.
  • Another study found that doxycycline plus streptomycin was more effective than doxycycline plus rifampicin in treating human brucellosis 2.
  • A systematic review of studies on brucellosis treatment found that regimens with lower treatment failure or relapse were considered more suitable for brucellosis treatment 4.

Antibiotic Regimens

  • Doxycycline-rifampin is a commonly used regimen for treating brucellosis, but it has been found to have a higher relapse rate compared to other regimens 3, 2.
  • The addition of gentamicin to doxycycline-rifampin has been found to decrease the rate of relapses 3.
  • Doxycycline plus streptomycin has been found to be more effective than doxycycline plus rifampicin in treating human brucellosis 2, 5.
  • Quinolone plus rifampicin has been found to be slightly better tolerated than doxycycline plus rifampicin, but with no significant difference in overall effectiveness 2.

Treatment Outcomes

  • A study found that the combination of oral doxycycline for 45 days plus intramuscular gentamicin for 7 days was equally as effective as traditional therapy using doxycycline for 45 days plus streptomycin for 14 days 5.
  • Another study found that the addition of amikacin to doxycycline-rifampin had a higher efficacy and more rapid action in terms of relief of symptoms, but with no significant difference in drug side-effects and disease relapse 6.
  • A systematic review found that higher relapse rates were associated with monotherapy and short-term treatment regimens 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antibiotics for treating human brucellosis.

The Cochrane database of systematic reviews, 2012

Research

Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006

Research

Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.